| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/25/2011 | EP1697400B1 Biphenyl-substituted antibacterial macrocycles |
| 05/25/2011 | EP1581248B1 Modification of feeding behaviour and weight control by oxyntomodulin |
| 05/25/2011 | EP1536823B1 Use of erythopoietin |
| 05/25/2011 | EP1515754B1 Beta-2-glycoprotein 1 is an inhibitor of angiogenesis |
| 05/25/2011 | EP1499731B1 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 05/25/2011 | EP1497326B1 Prothrombin activating protein |
| 05/25/2011 | EP1478666B1 Dermopharmaceutically and cosmetically active oligopeptides |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1381384B1 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha |
| 05/25/2011 | EP1374902B1 Anti-AILIM antibodies for the treatment of Crohn's disease |
| 05/25/2011 | EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 05/25/2011 | EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity |
| 05/25/2011 | EP1325112B1 Methods of isolating bipotent hepatic progenitor cells |
| 05/25/2011 | EP1294361B1 Compositions and methods to improve the oral absorption of antimicrobial agents |
| 05/25/2011 | EP1267942B1 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 05/25/2011 | EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 05/25/2011 | EP0959896B1 Method of producing secreted truncated variants of human thyrotropin receptor |
| 05/25/2011 | CN1863501B Peptide-based conditioners and colorants for hair, skin, and nails |
| 05/25/2011 | CN1845757B Use of cell factor mixture in preparing medicine for pre-sensitizing cancer and pharmaceutical composition for treating cancer |
| 05/25/2011 | CN1816538B Preventive or therapeutic composition for viral infectious disease |
| 05/25/2011 | CN1786031B Glucagon kind polypeptide-1 analogue, its preparation method and application |
| 05/25/2011 | CN1772897B Cell factor with several functions |
| 05/25/2011 | CN1730494B Cobratide modified by polyethylene glycol, its preparation method and uses |
| 05/25/2011 | CN102076855A Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 05/25/2011 | CN102076353A Derivatised hybrid peptides of amylin and salmon calcitonin |
| 05/25/2011 | CN102076352A Fgf-9 and its use relating to blood vessels |
| 05/25/2011 | CN102076351A Pharmaceutical agent for promoting functional regeneration of damaged tissue |
| 05/25/2011 | CN102076350A Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 05/25/2011 | CN102076214A 释放胃泌素的肽化合物 Gastrin releasing peptide compounds |
| 05/25/2011 | CN102071239A Anti-tumor mung bean polypeptide, preparation method thereof and application thereof to tumors |
| 05/25/2011 | CN102071184A Tabanusyao Macquart antithrombotic enzyme tablysin and gene and application thereof |
| 05/25/2011 | CN102070895A Core-shell microcapsule and preparation method thereof |
| 05/25/2011 | CN102070717A Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070712A VEGF-A (vascular endothelial growth factor-A) protein and use thereof |
| 05/25/2011 | CN102070711A Tissue factor pathway inhibitor (TFPI), preparation method thereof and application thereof |
| 05/25/2011 | CN102070704A Entire gene sequence of severe fever with thrombocytopenia syndrome virus (SFTSV) and application |
| 05/25/2011 | CN102070703A Methods for preparing purified daptomycin |
| 05/25/2011 | CN102068700A Phenylboronic acid polyethylene glycol gel and application thereof serving as glucose-sensitive material |
| 05/25/2011 | CN102068689A Swine alum powder |
| 05/25/2011 | CN102068688A Application of mechno-growth factor and E peptide thereof to preparation of medicaments and materials for treating osteoporosis or bone defect |
| 05/25/2011 | CN102068687A Nano and micro encapsulation and release of secretin |
| 05/25/2011 | CN102068686A New application of interleukin-12 |
| 05/25/2011 | CN102068685A Terlipressin preparation and preparations method thereof |
| 05/25/2011 | CN102068684A Perfusate and preparation method thereof for treating cow recessive mastitis |
| 05/25/2011 | CN102068488A Traditional Chinese medicinal composition and preparation method for granules thereof |
| 05/25/2011 | CN102068460A Earthworm protein-containing buccal instant preparation, preparation method and application thereof |
| 05/25/2011 | CN101670114B Compound of survivin and heat shock protein, preparation method and applications thereof |
| 05/25/2011 | CN101637220B Anti-virus feed additive for reducing cholesterol, production process thereof and application |
| 05/25/2011 | CN101519451B Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof |
| 05/25/2011 | CN101492719B Uses of CXorf41 gene |
| 05/25/2011 | CN101481692B Non-blood serum preparation of recombinant human blood coagulation factor IX |
| 05/25/2011 | CN101361972B Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 05/25/2011 | CN101265296B Reptile cathelicidin antibiotic peptide and derivatives, and application thereof |
| 05/25/2011 | CN101249278B Bone induction material and preparation method and application thereof |
| 05/25/2011 | CN101237870B Concomitant pharmaceutical agents and use thereof |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101120015B Interleukin-15 antagonist peptide |
| 05/25/2011 | CN101052651B Caspase-2 inhibitors and their biological applications |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947805 BCMA polypeptides and uses thereof |
| 05/24/2011 | US7947804 Vesicle trafficking proteins |
| 05/24/2011 | US7947731 Administering an agent that enhances Cyclic AMP response element binding protein (CREB) pathway function, training the animal to improve performance in the cognitive task; for people with central nervous system disorders |
| 05/24/2011 | US7947657 Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA) |
| 05/24/2011 | US7947655 Methods for making proteins containing free cysteine residues |
| 05/24/2011 | US7947654 Pharmaceutical formulations |
| 05/24/2011 | US7947652 Compositions and methods for modulating PGC-1α to treat huntington's disease |
| 05/24/2011 | US7947651 Secreted frizzled related protein, sFRP, fragments and methods of use thereof |
| 05/24/2011 | US7947650 Article of manufacture |
| 05/24/2011 | US7947649 Liquid buffered GDF-5 formulations |
| 05/24/2011 | US7947646 Variant activin receptor polypeptides |
| 05/24/2011 | US7947645 APO E analogs and methods for their use |
| 05/24/2011 | US7947473 Methods for expression and purification of pegylated recombinant human growth hormone containing a non-naturally encoded keto amino acid |
| 05/24/2011 | US7947472 An expression vector comprising a sequence of human DNA encoding vascular endothelial growth factor-D (VEGF-D) or a fragment having the biological activity of VEGF-D, inserted into a mammalian expression vector |
| 05/24/2011 | US7947469 Protein comprising receptor nucleotide sequences associated with viral binding and/or infection for use in prevention and treatment of viral and autoimmune diseases; viricides |
| 05/24/2011 | US7947466 Fluorescence based screening assays are provided that allow for the for identification of agents that selectively bind to a ligand-gated ion channels (LGIC); fluorescence resonance energy transfer (FRET) |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947459 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/24/2011 | US7947458 Placental human neurokinin B precursor |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947449 Methods of diagnosing pre-eclampsia or eclampsia |
| 05/24/2011 | US7947304 Human growth hormone patch formulations |
| 05/24/2011 | US7947303 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/24/2011 | US7947299 Compositions and techniques for localized therapy |
| 05/24/2011 | US7947291 Modified surface antigen |
| 05/24/2011 | US7947289 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 05/24/2011 | US7947288 Viral particles encoding multifunctional cytokines |
| 05/24/2011 | US7947287 Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors |
| 05/24/2011 | US7947282 Methods of treatment using vascular occlusion in combination therapies |
| 05/24/2011 | US7947278 administer effective dose of human Egfl7 polypeptide agonist; intravenous, intra-arterial, intra-pericardial, systemic, subcutaneous, intramuscular, by inhalation, topical, transdermal; tumor growth, atherosclerosis, diabetic retinopathy, age-related maculopathy, and retrolental fibroplasia |
| 05/24/2011 | US7947277 Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders |
| 05/24/2011 | US7947276 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 05/24/2011 | US7947270 Using multifunctional enzyme having chymotrypsin, trypsin, elastase, collagenase and/or exopeptidase activity |
| 05/24/2011 | US7947266 Perivascular mesenchymal precursor cells |
| 05/24/2011 | US7947265 Fusion proteins and methods for modulation of immune response |
| 05/24/2011 | US7947264 TGF-β3 mutants |
| 05/24/2011 | US7947261 Moiety is positioned between a water-soluble polymer and a reactive group; water soluble polymer such as polyethylene glycol containing a urethane linkage moiety for example, and a reactive group for conjugating with biodrugs |
| 05/24/2011 | US7947077 Method of producing a composite material, a composite material so produced and its application |
| 05/24/2011 | CA2531239C Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 05/24/2011 | CA2493764C Improved treatment of cancer with glutamine |